Insider · CIK 0001643934
Dagmar Rosa-Bjorkeson
Files at ICPT (INTERCEPT PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
Dagmar Rosa-Bjorkeson files SEC Form 4 as director at ICPT (INTERCEPT PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dagmar Rosa-Bjorkeson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | UTender of shares Common Stock | -14,766 | $19.00 | $281k | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -11,625 | $19.00 | $221k | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -17,719 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -12,790 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -12,547 | - | - | 0 | Nov 13, 2023 |
Questions about Dagmar Rosa-Bjorkeson
Answered from the filings on this page, as of the latest one.
Is Dagmar Rosa-Bjorkeson buying or selling?
Dagmar Rosa-Bjorkeson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dagmar Rosa-Bjorkeson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dagmar Rosa-Bjorkeson has 0.
Where does Dagmar Rosa-Bjorkeson file Form 4?
Dagmar Rosa-Bjorkeson has filed Form 4 at ICPT (INTERCEPT PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.